Spectrawave
Bedford, US · Founded 2017 · Delaware corporation · 24 employees on LinkedIn · 5 known investors
SpectraWAVE develops optical and computational imaging technologies to diagnose and guide treatment decisions for patients with coronary artery disease and cardiovascular disease. The company operates vertically integrated design, manufacturing, and commercialization operations for its medical devices.
Founders & leadership
Spectrawave was founded in 2017 by Eman Namati, Guillermo Tearney, Gregg Stone, James Muller, and Jeffrey O'Donnell.
EN
Eman NamatiPresident & CEO
GT
Guillermo TearneyFounder; Professor of Pathology, Massachusetts General Hospital
GS
Gregg StoneFounder; Professor of Medicine, Mount Sinai Heart Health System
JM
James MullerFounder; Cardiologist, Brigham and Women's Hospital
JO
Jeffrey O'DonnellFounder; Managing General Partner, Runway Healthcare
VW
Vivek WalimbeChief Operating Officer
BD
Brad DavisChief Commercial Officer
BK
Bill KellyChief Financial Officer
JH
Jonathan HillChief Medical Officer
ES
Eric SwansonNamed on SEC filing
MS
Martin SeifertNamed on SEC filing
Board
PL
Investors · 5
Reported raises · per SEC filings
Form D private placements$66.7M disclosed across 2 rounds · 2019–2024
▶$50.3MraisedOct 2024 · 33 investors · OtherRule 506(b)
▶$50.3MraisedOct 2024 · 33 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Eman NamatiExecutive Officer, Director
- Paul LaVioletteDirector
- Gerry BrunkDirector
- Bill LittleDirector
- David NeustaedterDirector
- Brian SmithDirector
- Kadir KadhiresanDirector
- Offering amount
- $50.3M
- Amount sold
- $50.3M
- First sale
- Sep 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$16.4MraisedMay 2019 · 19 investors · OtherRule 506(b)
▶$16.4MraisedMay 2019 · 19 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Eric SwansonDirector
- Martin SeifertExecutive Officer, Director
- Steven HochbergDirector
- Guillermo TearneyDirector
- Offering amount
- $16.4M
- Amount sold
- $16.4M
- First sale
- May 2019
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 5
by search overlapBoston Scientific10 shared keywordsBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
Cqmedical9 shared keywordsCQ Medical develops patient positioning and immobilization products used in radiation therapy, including devices for brachytherapy, SBRT, SRS, and proton treatments. Its offerings serve oncology and radiotherapy clinicians treating cancer and conditions such as osteoarthritis.
Itnonline9 shared keywordsITN (Imaging Technology News) is an online trade publication covering radiology and medical imaging, reporting on news, products, and clinical developments across modalities like CT, ultrasound, and breast imaging. It serves radiology professionals, imaging departments, and healthcare technology providers.
Sonavex8 shared keywordsSonavex develops medical device technologies focused on vascular access and related clinical applications, drawing on ultrasound-based imaging and monitoring products. The company serves clinical and surgical care settings, particularly in the dialysis and renal care space.
Rf Surgical7 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Companies competing with Spectrawave for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Spectrawave do?
- SpectraWAVE develops optical and computational imaging technologies to diagnose and guide treatment decisions for patients with coronary artery disease and cardiovascular disease. The company operates vertically integrated design, manufacturing, and commercialization operations for its medical devices.
- Who founded Spectrawave?
- Spectrawave was founded by Eman Namati, Guillermo Tearney, Gregg Stone, James Muller, Jeffrey O'Donnell in 2017.
- Who are Spectrawave's investors?
- Spectrawave's investors include Lumira Ventures, S3 Ventures, SV Health Investors, Deerfield Management Company, Johnson & Johnson Innovation – JJDC.
- How much funding has Spectrawave raised?
- Spectrawave has disclosed $66.7M raised across 2 rounds.
- Where is Spectrawave headquartered?
- Spectrawave is headquartered in Bedford, US.